Figure 2. Gains in Progression-Free Survival (PFS) of 82 Pan-Canadian Oncology Drug Review (pCODR) Submissions With Data Available at the Time of Assessment.

The dashed blue line represents the overall median gain in PFS, excluding values of 0 months (ie, no statistically significant difference between the intervention and comparator). The orange vertical lines represent the first and third quartile of PFS. Median (interquartile range) PFS gains were 4.0 (2.4-7.1) months.